(2026). ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer. Molecular Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"ZW4864‐mediated Inhibition of the β‐catenin/BCL9/BCL9L Complex Reveals Therapeutic Potential in Bladder Cancer."
Molecular Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"ZW4864‐mediated Inhibition of the β‐catenin/BCL9/BCL9L Complex Reveals Therapeutic Potential in Bladder Cancer."
Molecular Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.